Patient characteristics
| . | t(9;22) . | t(v;22) . | ACAs (except −Y) . | (−Y) . |
|---|---|---|---|---|
| n | 1003 | 69 | 41 | 38 |
| Median age, y (range) | ||||
| All | 52 (16-87) | 54 (16-88) | 48 (18-72) | 62 (24-79) |
| Male | 51 (16-87) | 54 (16-88) | 45 (23-72) | 62 (24-79) |
| Female | 55 (16-83) | 54.5 (17-70) | 53 (18-69) | - |
| Male, % | 59 | 57 | 59 | 100 |
| EUTOS score, % | ||||
| Low | 90.2 | 80.3 | 87.5 | 94.4 |
| High | 9.8 | 19.7 | 12.5 | 5.6 |
| Euro score, % | ||||
| Low | 35.3 | 27.5 | 43.9 | 39.4 |
| Intermediate | 54.8 | 55.1 | 41.5 | 51.5 |
| High | 9.9 | 17.4 | 14.6 | 9.1 |
| Median follow-up, mo | 64.1 | 63.0 | 72.7 | 58.6 |
| . | t(9;22) . | t(v;22) . | ACAs (except −Y) . | (−Y) . |
|---|---|---|---|---|
| n | 1003 | 69 | 41 | 38 |
| Median age, y (range) | ||||
| All | 52 (16-87) | 54 (16-88) | 48 (18-72) | 62 (24-79) |
| Male | 51 (16-87) | 54 (16-88) | 45 (23-72) | 62 (24-79) |
| Female | 55 (16-83) | 54.5 (17-70) | 53 (18-69) | - |
| Male, % | 59 | 57 | 59 | 100 |
| EUTOS score, % | ||||
| Low | 90.2 | 80.3 | 87.5 | 94.4 |
| High | 9.8 | 19.7 | 12.5 | 5.6 |
| Euro score, % | ||||
| Low | 35.3 | 27.5 | 43.9 | 39.4 |
| Intermediate | 54.8 | 55.1 | 41.5 | 51.5 |
| High | 9.9 | 17.4 | 14.6 | 9.1 |
| Median follow-up, mo | 64.1 | 63.0 | 72.7 | 58.6 |
Cytogenetic analyses were made and interpreted according to ISCN 2009.29
n indicates number; and ACA, additional clonal cytogenetic alterations.